CVS Health Corporation CVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 107.75B | 105.46B | 99.85B | 105.10B | 102.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.75B | 105.46B | 99.85B | 105.10B | 102.24B |
| Cost of Revenue | 93.50B | 90.35B | 84.80B | 92.13B | 89.07B |
| Gross Profit | 14.25B | 15.11B | 15.05B | 12.97B | 13.17B |
| SG&A Expenses | 11.32B | 11.04B | 10.93B | 11.32B | 10.86B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 104.82B | 101.38B | 95.73B | 103.45B | 99.92B |
| Operating Income | 2.93B | 4.07B | 4.12B | 1.65B | 2.32B |
| Income Before Tax | 2.85B | 3.98B | 3.94B | 1.35B | -3.48B |
| Income Tax Expenses | 678.00M | 982.00M | 981.00M | -1.57B | 508.00M |
| Earnings from Continuing Operations | 2.17B | 3.00B | 2.96B | 2.92B | -3.99B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | -16.00M | -14.00M | 20.00M | 15.00M |
| Net Income | 2.17B | 2.98B | 2.94B | 2.94B | -3.98B |
| EBIT | 2.93B | 4.07B | 4.12B | 1.65B | 2.32B |
| EBITDA | 4.06B | 5.20B | 5.23B | 2.80B | 3.45B |
| EPS Basic | 1.69 | 2.33 | 2.31 | 2.32 | -3.13 |
| Normalized Basic EPS | 1.40 | 1.94 | 1.93 | 0.69 | 1.09 |
| EPS Diluted | 1.68 | 2.31 | 2.30 | 2.31 | -3.13 |
| Normalized Diluted EPS | 1.39 | 1.92 | 1.92 | 0.69 | 1.09 |
| Average Basic Shares Outstanding | 1.28B | 1.28B | 1.27B | 1.27B | 1.27B |
| Average Diluted Shares Outstanding | 1.29B | 1.29B | 1.28B | 1.28B | 1.27B |
| Dividend Per Share | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
| Payout Ratio | 39.27% | 29.47% | 28.78% | 28.71% | -21.28% |